Atrium Therapeutics Announces $50 Million Private Placement
Atrium Therapeutics announced a $50 million private placement with institutional investors including Sirenia Capital, Aberdeen Investments, Montanova, Sessa Capital and Casdin Capital. The deal comprises 5,170,384 shares at $7.93 and pre-funded warrants on up to 1,134,930 shares at $7.929, priced at-the-market under Nasdaq rules; closing is expected around October 9, 2026.
Key figures
- Deal Value Usd
- 50000000
- Offering Price
- 7.93
- Pricing
- at-the-market under Nasdaq rules
- Cash runway
- through 2028
- Common shares
- 5170384
- Prefunded warrant price
- 7.929
- Prefunded warrant shares
- 1134930
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.